Kirkwood Site - Health Sciences North
Greater Sudbury, Ontario, P3E 1X3, Canada
NCT Number: NCT04504474
The study is an investigation to determine co-morbid symptoms between adult major depressive disorder (MDD) and adult attention-deficit hyperactivity disorder (ADHD) using a novel statistical technique called network analysis.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Greater Sudbury, Ontario, P3E 1X3, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: September 8, 2021
Characterize the ADHD/MDD symptom network in a psychiatric outpatient setting comprised of adults
Time frame: September 8, 2021
Determine the stability and reliability of this network
Time frame: September 8, 2021
Determine the central symptoms that lead to co-activation of ADHD/MDD clusters
Looking for future studies?
Notify MeHealth Sciences North Research Institute
Other
Network Analysis of Co-morbid Symptoms of Adult Major Depressive Disorder and Attention-deficit Hyperactivity Disorder in an Outpatient Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07838311
ADHD, Attention Deficit Disorder with Hyperactivity
Boston, Massachusetts, United States
View Trial DetailsNCT07836244
ADHD, Attention Deficit Disorder with Hyperactivity
Xi'an, Shaanxi, China
View Trial DetailsNCT05842330
ADHD, Attention Deficit Disorder with Hyperactivity
Geneva, Canton of Geneva, Switzerland
View Trial DetailsNCT07566468
ADHD, Anxiety Disorders
Bethesda, Maryland, United States
View Trial Details